5589320 FOLLOW‐UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... by Dijk, M.J., Rab, M.A.E., Oirschot, B.A., Bos, J.F., Derichs, C., Rijneveld, A.W., Cnossen, M.H., Nur, E., Biemond, B.J., Bartels, M., Jans, J.J.M., Solinge, W.W., Schutgens, R.E.G., Wijk, R., Beers, E.J.

Get full text

448 Exposure to EGFR inhibitors influences release of extracellular vesicles by tumor cells by van der Meel, R, van Dommelen, S.M, de Corte, P, Coimbra, M, van Solinge, W.W, Vader, P, Schiffelers, R.M

Get full text

Inappropriate laboratory testing in internal medicine inpatients: Prevalence, causes and interventions by Vrijsen, B.E.L., Naaktgeboren, C.A., Vos, L.M., van Solinge, W.W., Kaasjager, H.A.H., ten Berg, M.J.

Get full text

Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease by Marsh, Anne, Schiffelers, Raymond, Kuypers, Frans, Larkin, Sandra, Gildengorin, Ginny, Solinge, Wouter, Hoppe, Carolyn

Get full text

3075 Thrombocytopenia (TCP) in adult cancer patients receiving cytotoxic chemotherapy: incidence and relative risk estimates from a retrospective hospital-based cohort study by ten Berg, M.J, Van den Bemt, P.M.L.A, Shantakumar, S, Bennett, D, Voest, E.E, Huisman, A, Van Solinge, W.W, Egberts, T.C.G

Get full text

Anti‐inflammatory compounds to reduce infarct size in large‐animal models of myocardial infarction: A meta‐analysis by van Hout, G.P.J., Jansen of Lorkeers, S.J., Wever, K.E., Sena, E.S., van Solinge, W.W., Doevendans, P.A., Pasterkamp, G., Chamuleau, S.A.J., Hoefer, I.E.

Get full text

Pyruvate kinase deficient hemolytic anemia in the Northern Irish population by Percy, M.J., van Wijk, R., Haggan, S., Savage, G.A., Boyd, K., Dempsey, S., Hamilton, J., Kettle, P., Kyle, A., Shepherd, C.W., van Solinge, W.W., Lappin, T.R.J., McMullin, M.F.

Get full text